Glial cell line neurotrophic factor-family receptor α-1 is present in central neurons with distinct phenotypes

Neuroscience

Volumn 116, Issue 1, 2003, Pages 261-273

  Sarabi, A ^a   Hoffer, B J ^a   Olson, L ^b   Morales, M ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Glial cell line neurotrophic factor; Glutamic acid decarboxylase; Interneurons; Serotonin and septum

Indexed keywords

4 AMINOBUTYRIC ACID; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR FAMILY RECEPTOR ALPHA 1; NITRIC OXIDE SYNTHASE; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CATECHOLAMINE NERVE CELL; CELL ACTIVITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LOCUS CERULEUS; MALE; MOTONEURON; NERVE CELL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPHE NUCLEUS; RAT; SEPTUM PELLUCIDUM; SEROTONINERGIC NERVE CELL; SPINAL CORD; THALAMUS NUCLEUS;

ACETYLCHOLINE; ANIMALS; CENTRAL NERVOUS SYSTEM; CHOLINE O-ACETYLTRANSFERASE; GAMMA-AMINOBUTYRIC ACID; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; GLUTAMATE DECARBOXYLASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEURONS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; TYROSINE 3-MONOOXYGENASE;

EID: 0037439171     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00559-6     Document Type: Article

References (51)

1. Arenas E., Trupp M., Akerud P., Ibanez C.F. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron. 15:1995;1465-1473.
2. Beck K.D., Valverde J., Alexi T., Poulson K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
3. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci. 18:1995;223-253.
4. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., Granholm A. Glial cell line-derived neurotrophic factor supports survival of injured dopaminergic neurons. J Comp Neurol. 355:1995;479-489.
5. Buj-Bello A., Buchman V.L., Horton A., Rosenthal A., Davies A.M. GDNF is an age specific survival factor for sensory and autonomic neurons. Neuron. 15:1995;821-828.
6. Choi-Lundberg D.L., Lin Q., Chang Y.N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
7. Dawson V.L., Dawson T.M. Nitric oxide neurotoxicity. J Chem Neuroanat. 10:1996;179-190.
8. Dawson T.M., Snyder S.H. Gases as biological messengers Nitric oxide and carbon monoxide in the brain . J Neurosci. 14:1994;5147-5159.
9. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA. 90:1993;9808-9812.
10. Durbec P., Marcos-Gutierrez C.V., Kilkenny C., Grigorious M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M., Sariola H., Pachnis V. GDNF signaling through the Ret receptor tyrosine kinase. Nature. 381:1996;789-792.
11. Dun N.J., Dun S.L., Forstermann U. Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience. 59:1994;429-445.
12. Ebendal T., Tomac A., Hoffer B.J., Olson L. Glial cell line-derived neurotrophic factor stimulates fiber formation and survival in cultured neuron from peripheral autonomic ganglia. J Neurosci Res. 40:1995;276-284.
13. Freund T.F., Antal M. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature. 336:1988;170-173.
14. Gash D.M., Zhang Z., Gerhardt G. Neuroprotective and neurorestorative properties of GDNF. Ann Neurol. 3:(Suppl 1):1998;121-125.
15. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
16. Gash D.M., Zhang Z., Cass W.A., Ovadia A., Simmerman L., Martin D., Russell D., Collins F., Hoffer B.J., Gerhardt G.A. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J Comp Neurol. 363:1995;345-358.
17. Gerra G., Zaimovic A., Giucastro G., Maestri D., Monica C., Sartori R., Caccavari R., Delsignore R. Serotonergic function after (+/-)3, 4methylene dioxymethamphetamine ('Ecstasy') in humans. Int Clin Psychopharmacol. 13:1998;1-9.
18. Halliday G.M., McCann H.L., Pamphlett R., Brooks W.S., Creasey H., McCusker E., Cotton R.G., Broe G.A., Harper C.G. Brain stem serotonin-synthesizing neurons in Alzheimer's disease A clinicopathological correlation . Acta Neuropathol (Berl). 84:1992;638-650.
19. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R.A., Koliatsos V.E., Rosenthal A. GDNF A potent survival factor for motoneurons present in peripheral nerve and muscle . Science. 266:1994;1062-1064.
20. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.-F., Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett. 182:1994;107-111.
21. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the rat protein tyrosine kinase is mediated by GDNFR-α a novel receptor for GDNF. Cell. 85:1996;1113-1124.
22. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 290:2000;767-773.
23. Launay J.M., Callebert J., Bondoux D., Loric S., Maroteaux L. Serotonin receptors and therapeutics. Cell Mol Biol. 40:1994;327-336.
24. Li L., Wu W., Lin L.F., Lei M., Oppenheim R.W., Houenou L.J. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci USA. 92:1995;9771-9775.
25. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
26. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet. 352:1998;1433-1437.
27. Moore M.W., Klein R.D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., Carver-Moore K., Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature. 382:1996;76-79.
28. Morales M., Bloom F.E. The 5-HT3 receptor is present in different subpopulation of GABAergic neurons in the rat telencephalon. J Neurosci. 17:1997;3157-3167.
29. Mount H.T.J., Dean D.O., Alberch J., Dreyfus C.F., Black I.B. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of purkinje cells. Proc Natl Acad Sci USA. 92:1995;9092-9096.
30. Nosrat C.A., Tomac A., Hoffer B.J., Olson L. Cellular and patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp Brain Res. 115:1997;410-422.
31. O'Shea E., Esteban B., Camarero J., Green A.R., Colado M.I. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ("Ecstasy") on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology. 40:2001;65-74.
32. Pascual M., Rocamora N., Acsady L., Freund T.F., Soriano E. Expression of nerve growth factor and neurotrophin-3 mRNAs in hippocampal interneurons Morphological characterization, levels of expression, and colocalization of nerve growth factor and neurotrophin-3 . J Comp Neurol. 395:1998;73-90.
33. Pichel J.G., Shen L., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., Lee E.J., Huang S.P., Saarma M., Hoffer B.J., Sariola H., Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 382:1996;73-76.
34. Poteryaev D., Titievsky A., Sun Y.F., Thomas-Crusells J., Lindahl M., Billaud M., Arumae U., Saarma M. GDNF triggers a novel ret-independent src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha 1. FEBS Lett. 463:1999;63-66.
35. Price M.L., Hoffer B.J., Granholm A.C. Effects of GDNF on fetal septal forebrain transplants in oculo. Exp Neurol. 141:1996;181-189.
36. Ricaurte G.A., McCann U.D., Szabo Z., Scheffel U. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Toxicol Lett. 15:2000;112-113.
37. Rocamora N., Pascual M., Acsady L., de Lecea L., Freund T.F., Soriano E. Expression of NGF and NT3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J Neurosci. 16:1996;3991-4004.
38. Sarabi A., Hoffer B.J., Olson L., Morales M. GFRalpha-1 is expressed in parvalbumin GABAergic neurons in the hippocampus. Brain Res. 877:2000;62-270.
39. Sarabi A., Hoffer B.J., Olson L., Morales M. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J Comp Neurol. 441:2001;106-117.
40. Steininger T.L., Wainer B.H., Klein R., Barbacid M., Palfrey H.C., Steriade M. The GABAergic reticular nucleus A preferential target of corticothalamic projections . Proc Natl Acad Sci USA. 98:2001;3625-3627.
41. Stromberg I., Bjorklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B.J., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol. 124:1993;401-412.
42. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull. 41:1996;131-141.
43. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
44. Treanor J.J., Goodman L., De Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
45. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:1996;785-789.
46. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic action in the adult rat CNS. J Neurosci. 17:1997;3554-3567.
47. Trupp M., Scott R., Whittemore S.R., Ibanez C.F. Ret-dependent and independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem. 274:1999;20885-20894.
48. Tseng J.L., Baetge E.E., Zurn A.D., Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci. 17:1997;325-333.
49. Wang Q.P., Guan J.L., Nakai Y. Distribution and synaptic relations of NOS neurons in the dorsal raphe nucleus A comparison to 5-HT neurons . Brain Res Bull. 37:1995;177-187.
50. Williams L.R., Inouye G., Cummins V., Pelleymounter M.A. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor . J Pharmacol Exp Ther. 277:1996;1140-1151.
51. Winkler C., Sauer H., Lee C.S., Bjorklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci. 16:1996;7206-7215.